Axovant Sciences Ltd. (AXON) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 920 transactions totaling $1.2B, demonstrating a bearish sentiment with -$407.0M in net insider flow. The most recent transaction on Dec 19, 2025 involved a sale of 1,134 shares valued at $680.4K.
No significant insider buying has been recorded for AXON in the recent period.
No significant insider selling has been recorded for AXON in the recent period.
Based on recent SEC filings, insider sentiment for AXON is bearish with an Insider Alignment Score of 33/100 and a net flow of -$407.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Axovant Sciences Ltd. (AXON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading AXON stock, having executed 920 transactions in the past 90 days. The most active insider is Patrick W. Smith (Executive), who has made 386 transactions totaling $1.6B.
Get notified when executives and directors at AXON file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | H. Mak Jennifer | Executive | Sale | 1,134 | $600.00 | $680.4K | Large |
| Dec 15, 2025 | Elizabeth Kalinowski Caitlin | Executive | Gift | 180 | $N/A | $0 | |
| Dec 15, 2025 | H. Mak Jennifer | Executive | Award | 1,359.82 | $N/A | $0 | |
| Dec 11, 2025 | Bagley Brittany | Executive | Sale | 2,000 | $580.00 | $1.2M | Large |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 1,685 | $550.49 | $927.6K | Large |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 3,655 | $551.60 | $2.0M | Large |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 8,723 | $553.22 | $4.8M | Large |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 1,132 | $554.34 | $627.5K | Large |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 102 | $555.14 | $56.6K | |
| Dec 8, 2025 | Isner Joshua | Executive | Sale | 4,703 | $552.52 | $2.6M | Large |
| Dec 8, 2025 | W. Smith Patrick | Executive | Sale | 294 | $549.56 | $161.6K | |
| Dec 8, 2025 | W. Smith Patrick | Executive | Sale | 4,522 | $551.62 | $2.5M | Large |
| Dec 8, 2025 | W. Smith Patrick | Executive | Sale | 1,887 | $550.68 | $1.0M | Large |
| Dec 8, 2025 | W. Smith Patrick | Executive | Sale | 1,402 | $552.42 | $774.5K | Large |
| Dec 8, 2025 | W. Smith Patrick | Executive | Sale | 140 | $555.19 | $77.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 45 | $1.0B | 41.0% |
Sale(S) | 666 | $799.2M | 32.6% |
Purchase(P) | 43 | $392.2M | 16.0% |
Payment(F) | 43 | $195.7M | 8.0% |
Award(A) | 112 | $61.1M | 2.5% |
Gift(G) | 11 | $0 | 0.0% |
Insider selling pressure at Axovant Sciences Ltd. has increased, with 42 insiders executing 920 transactions across all time. Total sales of $799.2M significantly outpace purchases of $392.2M, resulting in a net outflow of $407.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.